tm
Seeing Is Believing
tm
Seeing Is Believing
KDNY is currently covered by 11 analysts with an average price target of $45.99. This is a potential upside of $5.6 (13.86%) from yesterday's end of day stock price of $40.39.
Chinook Therapeutics's activity chart (see below) currently has 19 price targets and 39 ratings on display. The stock rating distribution of KDNY is 62.5% BUY and 37.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 57.2% with an average time for these price targets to be met of 370.55 days.
Highest price target for KDNY is $42, Lowest price target is $30, average price target is $45.99.
Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 08-Aug-2023. First documented stock forecast 20-Apr-2015.
Currently out of the existing stock ratings of KDNY, 15 are a BUY (62.5%), 9 are a HOLD (37.5%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
42
$1.61 (3.99%)
36
8 months 11 days ago
2/3 (66.67%)
$1.68 (4.17%)
460
Hold
30
$-10.39 (-25.72%)
30
8 months 18 days ago
1/2 (50%)
$-10.29 (-25.54%)
189
Hold
40
$-0.39 (-0.97%)
40
9 months 29 days ago
8/8 (100%)
$1.63 (4.25%)
253
Hold
40
$-0.39 (-0.97%)
32
10 months 5 days ago
2/2 (100%)
$2.37 (6.30%)
500
Hold
41
$0.61 (1.51%)
43
10 months 6 days ago
1/3 (33.33%)
$3.13 (8.27%)
350
What is KDNY (Chinook Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KDNY (Chinook Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KDNY (Chinook Therapeutics)?
Which analyst is the currently most bullish on KDNY (Chinook Therapeutics)?
Which analyst is the currently most reserved on KDNY (Chinook Therapeutics)?
